obesity
Liam O’Mahony explores how diet influences the immune system through the metabolic activity of the gut microbiota.
Computer models combining oral bacteria, their metabolic functions, and saliva chemicals could better distinguish obese from healthy individuals compared with clinical measurements alone.
Probiotics protect against obesity and inflammation caused by high sugar intake, supporting their use as a preventive strategy for obesity-related diabetes.
AceCel is a promising way to help manage obesity by targeting gut bacteria and metabolism together.
Phages could be used as a drug delivery system for conditions such as inflammation and obesity.
Positive results from Phase 1 trial of BL-001, an innovative live biotherapeutic product (LBP) designed to replicate the metabolic effects of the ketogenic diet.
The discussion with Professor Alessio Fasano highlights the complex interplay between homeostatic, hedonic, and microbiota-driven mechanisms in regulating hunger.
The findings suggest that the composition of the gut microbiota in early life is not a key factor in obesity risk.
A recent study highlights the role of specific obesogenic microbes suggesting potential interventions through targeted regulation of M. rupellensis and myo-inositol metabolism.
The findings of a recent study suggest that Desulfovibrio can drive cancer progression, paving the way for therapeutic approached that targeting the gut microbiota.
